Filing Details
- Accession Number:
- 0001209191-21-002566
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-07 17:58:33
- Reporting Period:
- 2021-01-05
- Accepted Time:
- 2021-01-07 17:58:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1419600 | Flexion Therapeutics Inc | FLXN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1222950 | Scott Kelley | C/O Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-01-05 | 6,829 | $11.13 | 113,549 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale of shares of common stock to cover tax withholding obligations associated with the vesting of restricted stock unit awards granted to the Reporting Person on February 1, 2018, March 1, 2019, and March 2, 2020.
- The weighted average sale price for the transaction reported was $11.13. The shares were sold at a range of prices between $11.12 and $11.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- Includes 668 shares of Common Stock that were acquired by the Reporting Person on December 21, 2020, at $9.77 per share pursuant to the Issuer's Employee Stock Purchase Plan.
Billionaire Hedge Funds
